- Copy Number Variations (CNVs) are a major form of genomic variation in which sections of DNA are present in different numbers of copies among individuals or cells. Unlike a typical human genome in which many regions are present in two copies, one inherited from each parent, CNVs can involve the loss or gain of DNA segments. These changes can range from relatively small regions containing a few genes to much larger genomic segments spanning millions of DNA bases. Because CNVs can alter the amount of genetic material available to cells, they are important in human genetics, genetic disorders, development, disease susceptibility, and cancer.
- The two major forms of CNVs are deletions and duplications. A deletion reduces the number of copies of a particular DNA segment, while a duplication increases the number of copies. CNVs can therefore produce copy-number loss or copy-number gain. Some CNVs affect protein-coding genes, whereas others involve regulatory DNA, noncoding regions, or genomic segments containing several genes. The biological consequences depend on the size and location of the CNV, the genes involved, the number of copies present, and the sensitivity of those genes to changes in dosage.
- CNVs are closely related to structural variants, a broader category of genomic changes that can alter the organization or amount of DNA. Structural variants also include inversions, translocations, large insertions, and complex genomic rearrangements. CNVs are particularly important because they directly change the number of copies of genomic segments. Small CNVs can sometimes overlap with insertions and deletions (indels), while larger CNVs are generally considered structural variants. The boundaries between different classes of genomic variation can therefore depend partly on the size and genomic context of the change.
- One of the most important biological consequences of CNVs is their effect on gene dosage. Gene dosage refers to the amount of genetic material or gene product available from a particular gene or genomic region. A deletion can reduce gene dosage, whereas a duplication can increase it. Some genes tolerate these changes with little or no obvious effect, while others are highly sensitive to changes in copy number. Loss of one functional copy of a dosage-sensitive gene can contribute to haploinsufficiency, while excessive copies of a gene may cause abnormal increases in gene expression or protein production.
- Not every CNV causes disease. Many CNVs are naturally occurring forms of normal human genetic variation and can be found in healthy individuals. Such benign CNVs contribute to genetic diversity and can influence characteristics without producing a clinically significant disorder. Other CNVs can be pathogenic, meaning that they contribute directly to disease. Some have uncertain effects and may initially be classified as variants of uncertain significance (VUS) until additional evidence becomes available.
- CNVs can arise through several molecular mechanisms. One important mechanism is non-allelic homologous recombination (NAHR), which can occur when highly similar DNA sequences, such as segmental duplications, misalign during meiosis or DNA repair. Recombination between incorrectly aligned regions can produce deletions or duplications. CNVs can also arise through errors in DNA replication, abnormal repair of DNA breaks, and other DNA repair mechanisms.
- Replication-based mechanisms can produce CNVs when DNA replication machinery switches templates or encounters problematic genomic regions. Processes involving replication fork instability and template switching can generate complex copy-number changes. Non-homologous end joining (NHEJ) and other repair pathways can also contribute to genomic rearrangements. Repetitive DNA sequences can make some genomic regions particularly susceptible to these events.
- CNVs can occur in the germline, meaning they can be present in eggs or sperm and potentially passed from parents to children. They can also arise as de novo mutations, appearing for the first time in an individual rather than being inherited from either parent. In other situations, CNVs arise only in particular tissues or groups of cells. These are known as somatic CNVs and are especially important in cancer biology.
- CNVs can also contribute to genetic disorders by disrupting genes, altering gene dosage, changing regulatory regions, or modifying the structure of chromosomes. A deletion may remove an entire gene or several neighboring genes, while a duplication may increase the number of copies of dosage-sensitive genes. Larger CNVs can therefore produce complex clinical effects because several genes may be affected simultaneously.
- Some CNVs are associated with developmental disorders, neurological conditions, congenital abnormalities, and other genetic diseases. Their effects can vary substantially between individuals because the same genomic region may produce different outcomes depending on the exact breakpoints, additional genetic variants, environmental factors, and other biological influences. This variability is one reason that interpreting CNVs requires information beyond simply identifying a copy-number change.
- CNVs are also important in cancer genetics and cancer genomics. Tumor cells frequently acquire somatic changes in DNA copy number during cancer development. Amplification of an oncogene can increase its expression and promote abnormal cell growth, while deletion of a tumor suppressor gene can remove an important protective mechanism. Tumors can therefore contain extensive patterns of copy-number gains and losses that provide information about their genomic organization and biology.
- Copy-number changes can also affect gene regulation without directly removing or duplicating a protein-coding gene. A CNV may alter the number of copies of an enhancer, promoter, insulator, or other regulatory element. Such changes can modify gene expression and may be particularly important during development, when precise control of gene activity is required in specific tissues and at specific stages.
- CNVs may be inherited in different ways depending on their genomic location and origin. Some are transmitted through families according to recognizable inheritance patterns, while others occur de novo. Mosaicism can further complicate inheritance and diagnosis when a CNV is present in only a subset of cells. The proportion and distribution of affected cells can influence whether a CNV produces detectable biological or clinical effects.
- Detecting CNVs requires specialized genetic testing because some copy-number changes cannot be reliably identified using methods designed primarily for single-nucleotide variants. Chromosomal microarray testing is widely used to identify gains and losses of genomic material across the genome. Depending on the application, other methods such as quantitative PCR, multiplex ligation-dependent probe amplification, and targeted copy-number assays can also be used.
- Whole-genome sequencing (WGS) and whole-exome sequencing (WES) can provide additional information about copy-number changes. Sequencing-based CNV detection may use differences in read depth across genomic regions to identify relative gains and losses. WGS can provide broader genomic coverage than WES, although the ability to detect particular CNVs depends on the sequencing technology, coverage, bioinformatics methods, and genomic region involved.
- Long-read sequencing is increasingly useful for studying complex genomic regions and structural variation. Longer DNA reads can help resolve repetitive sequences and identify breakpoints that may be difficult to characterize using conventional short-read approaches. Combining different sequencing technologies can therefore improve the detection and characterization of complex CNVs and other structural variants.
- Interpreting a CNV requires determining its size, genomic location, genes and regulatory elements affected, inheritance pattern, population frequency, and available clinical evidence. Variant interpretation commonly incorporates information from population databases, clinical databases, laboratory studies, gene-dosage information, and evidence from affected individuals and families. A CNV that is common in healthy populations may be more likely to be benign, whereas a rare CNV affecting a dosage-sensitive disease gene may require further investigation.
- The interpretation of CNVs can be challenging when a genomic region contains several genes with different functions. Some CNVs may have multiple potential molecular consequences, while others may overlap regions whose biological functions are not yet fully understood. Continued research in functional genomics, transcriptomics, and other areas of molecular biology is helping researchers determine how specific copy-number changes influence gene expression and cellular processes.
- CNVs are also important in population genetics and human evolution. Differences in DNA copy number contribute to genetic diversity within and between populations. Some CNVs may influence adaptation by changing the dosage of genes involved in metabolism, immunity, environmental responses, or other biological functions. Studying CNVs across populations therefore provides information about the evolution and organization of the human genome.
- CNVs can interact with other forms of genetic variation, including single-nucleotide variants, indels, regulatory variants, and other structural variants. The combined effects of multiple genetic changes can influence phenotype and disease susceptibility. This highlights the importance of studying the genome as an integrated system rather than interpreting every variant in isolation.
- The study of CNVs is increasingly connected with precision medicine and genomic medicine. Understanding an individual’s copy-number profile can contribute to diagnosis, disease classification, cancer characterization, and in some circumstances treatment planning. In cancer, copy-number patterns may provide information about tumor biology, while in inherited disease, identifying a pathogenic CNV can help establish a molecular diagnosis and support family-based genetic evaluation.
- Modern research is also examining CNVs using genome-wide datasets, single-cell technologies, long-read sequencing, and advanced computational approaches. These methods are helping researchers identify previously difficult-to-detect copy-number changes, understand genomic instability, and investigate how CNVs influence gene expression and disease. As genomic technologies continue to improve, the classification and interpretation of CNVs are expected to become increasingly detailed.
- Overall, Copy Number Variations (CNVs) represent an important form of genomic variation involving gains or losses of DNA segments. They can be benign components of normal genetic diversity or contribute to genetic disorders, developmental conditions, and cancer. Their biological effects are closely connected with gene dosage, genomic architecture, regulatory mechanisms, and the functions of the genes involved. Understanding CNVs therefore provides an essential foundation for studying genetic mutations, structural variants, human genetic diversity, and disease-associated genomic changes.
